News Articles Tagged: Membrane-Active Peptide

PNC-27: A New Generation of Peptide Therapeutics for Cancer

Learn about PNC-27, a novel synthetic peptide that targets cancer cell membranes for necrosis, offering a p53-independent approach to cancer treatment.

Enhancing Lipophilicity: The Role of N-Succinimidyl Myristate in Research

Learn how N-Succinimidyl Myristate effectively enhances molecular lipophilicity, aiding research in membrane protein studies and lipidated molecule development.

Deciphering the 'L-Shape': The Structural Basis of Dermcidin-1L's Membrane Insertion

Delve into the structural intricacies of Dermcidin-1L. Explore its 'L-shaped' conformation and how it dictates its unique membrane insertion mechanism, providing crucial insights for antimicrobial peptide design.

The Precision of Peptide PNC-27: Targeting Cancer Cell Membranes for Necrosis

NINGBO INNO PHARMCHEM CO.,LTD. examines Peptide PNC-27, a molecule that uses HDM-2 binding to target cancer cell membranes and induce necrosis.

PNC-27 Peptide: A Breakthrough in Targeting Cancer Cell Membranes

NINGBO INNO PHARMCHEM CO.,LTD. examines Peptide PNC-27, a molecule that targets cancer cell membranes through HDM-2 binding to induce cell death.

Advancing Cancer Treatment: The Science Behind Peptide PNC-27's Selective Cell Killing

NINGBO INNO PHARMCHEM CO.,LTD. explores the scientific basis of Peptide PNC-27, a molecule designed to target and destroy cancer cells via membrane lysis.

Understanding PNC-27: A Membrane-Active Peptide for Targeted Cancer Therapy

Delve into the functional aspects of PNC-27, a membrane-active peptide that selectively targets cancer cells via HDM-2, offering a new paradigm in targeted cancer treatment.

PNC-27 Peptide: Revolutionizing Cancer Treatment Through Membrane Targeting

Learn about the cutting-edge PNC-27 peptide, its unique membrane-targeting strategy, and its impact on selective cancer cell necrosis, as explored in recent research.